Insider Selling: Inotiv, Inc. (NASDAQ:NOTV) CEO Sells $94,205.00 in Stock

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 22,700 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $4.15, for a total transaction of $94,205.00. Following the completion of the transaction, the chief executive officer now owns 1,030,209 shares of the company’s stock, valued at $4,275,367.35. This trade represents a 2.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Inotiv Stock Down 6.2 %

Shares of NASDAQ:NOTV opened at $3.92 on Friday. The firm has a fifty day moving average price of $4.43 and a two-hundred day moving average price of $2.80. The company has a market cap of $101.96 million, a price-to-earnings ratio of -0.94 and a beta of 3.58. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.37 and a quick ratio of 1.22. Inotiv, Inc. has a one year low of $1.23 and a one year high of $11.42.

Inotiv (NASDAQ:NOTV) last posted its quarterly earnings data on Wednesday, February 5th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 22.10% and a negative return on equity of 15.86%. Analysts anticipate that Inotiv, Inc. will post -0.75 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Vantage Point Financial LLC bought a new stake in Inotiv during the fourth quarter valued at approximately $1,393,000. KPP Advisory Services LLC raised its position in shares of Inotiv by 15.8% during the 4th quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock valued at $1,140,000 after buying an additional 37,549 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Inotiv by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock worth $427,000 after acquiring an additional 18,039 shares during the last quarter. Renaissance Technologies LLC grew its position in Inotiv by 29.9% in the second quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock worth $273,000 after acquiring an additional 37,800 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its stake in Inotiv by 612.5% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock valued at $527,000 after acquiring an additional 109,397 shares during the last quarter. Hedge funds and other institutional investors own 18.17% of the company’s stock.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.